Dr. Nagourney's Blog


Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

Robert A. Nagourney, MD

Robert A. Nagourney, MD

Dr. Robert Nagourney has been a pioneer in personalized cancer testing and research for over 20 years. He is founder and director of Nagourney Cancer Institute (formerly Rational Therapeutics), an accomplished research and testing lab in Long Beach, personalizing cancer patient treatments from all over the world. Dr. Nagourney is author of the book Outliving Cancer, blogger, practicing oncologist, and clinical professor at the University of California, Irvine.

Among his many accomplishments, as co-investigator on national cooperative trials, Dr. Nagourney is recognized for the introduction of Cisplatin/Gemcitabine doublets in the treatment of advanced ovarian and breast cancers. Also, Dr. Nagourney's group originally reported the effectiveness of this same drug combo for advanced bladder cancer at a research symposium in Washington DC, ten years before it became the treatment of choice.

He has been featured on national and local television such as CNN, ABC World News Tonight, CNBC and major newspapers such as the Wall Street Journal. He has also been featured internationally such as on the Australian TV show Good Medicine, and Univision's Primer Impacto.

He has also served as a reviewer and on the editorial boards of several journals including Clinical Cancer Research, British Journal of Cancer, Gynecologic Oncology, Cancer Research and the Journal of Medicinal Food.

Follow Dr. Nagourney on Twitter @RobertNagourney
Find me on:

Recent Posts

Overcoming Stage IV Ovarian Cancer: A Life Well-Lived
By Robert A. Nagourney, MD
In 2008, I met a delightful 88-year-old patient accompanied by her daughter. The patient had been successfully treated for...
Treating Stage IV Lung Cancer: “You can’t get there from here.”
By Robert A. Nagourney, MD
There is a joke about a traveling salesman who finds himself lost in the countryside and stops a farmer to ask directions to...
Interstate Oncology: Breast Cancer Patient On the Run
By Robert A. Nagourney, MD
Of the one million new breast cancer patients diagnosed each year worldwide, approximately 170,000 of these cases are triple...
There's Something Sweet About Evolutionary Biology
By Robert A. Nagourney, MD
Humans evolved around their food supply. The foods we eat, the herbs we consume, our sources of nutrition, indeed everything...
For Mantle Zone Lymphoma: What Goes Around Comes Around
By Robert A. Nagourney, MD
Mantle zone lymphoma represents approximately 6% of all non-Hodgkin lymphomas diagnosed in the US each year. It is named for...
Confronting Colorectal Cancer: A No-Holds-Barred Approach
By Robert A. Nagourney, MD
March is colorectal cancer awareness month. Colorectal cancer is the third most common cancer for both men and women in the US...
Treating an 83-yr-old With Neuroendocrine Cancer: All in Good Measure
By Robert A. Nagourney, MD
A recent editorial entitled "More Proof That Less Chemo is Best in Elderly Colorectal Cancer Patients" (David Kerr, Medscape,...

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.